JPS63209581A - Embedding culture of attachment-dependent animal normal cell - Google Patents

Embedding culture of attachment-dependent animal normal cell

Info

Publication number
JPS63209581A
JPS63209581A JP62041442A JP4144287A JPS63209581A JP S63209581 A JPS63209581 A JP S63209581A JP 62041442 A JP62041442 A JP 62041442A JP 4144287 A JP4144287 A JP 4144287A JP S63209581 A JPS63209581 A JP S63209581A
Authority
JP
Japan
Prior art keywords
cells
cell
carrier
alginic acid
microcarrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62041442A
Other languages
Japanese (ja)
Other versions
JPH07100029B2 (en
Inventor
Nobuyuki Shima
伸行 島
Kazumi Arai
新井 一三
Kanji Too
侃二 東尾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP62041442A priority Critical patent/JPH07100029B2/en
Publication of JPS63209581A publication Critical patent/JPS63209581A/en
Publication of JPH07100029B2 publication Critical patent/JPH07100029B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To make it possible to carry out high-density culture of titled cell in a large amount, by bonding attaching animal normal cells to a fine granular biological high polymer carrier and embedding the cell in gel of calcium alginate. CONSTITUTION:Attaching animal normal cell are seeded in a microcarrier consisting of a biological high polymer such as gelatin, collagen, etc., in such a cell density that 5-10 cells are bonded to one carrier and cultivated in 5% carbonic acid gas concentration atmosphere for 1-3hr. to bond the cells to the carrier. The microcarrier is blended with 1.6% solution alginic acid obtained by dissolving alginic acid in 0.85% sodium chloride injection in such a way that the final concentration of alginic acid gel is 0.3-1.0%. The mixed solution is added from a nozzle or a sterilized pipette to a solution obtained by adding 0.001-0.01% Tween80 to sterile calcium chloride to give a cell embedded microcarrier, which is cultivated in a medium.

Description

【発明の詳細な説明】 皮l上■[1光豆 本発明は、付着性の動物正常細胞を大量培養するための
包埋培養法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an embedding culture method for culturing adherent normal animal cells in large quantities.

従米狭班 従来、付着性で生育する培養細胞、すなわち、付着依存
性細胞を大量培養するには、細胞を表面積が大きい円筒
型の瓶の表面に付着さセ、瓶を回転させて培養する回転
皿培養又は微粒子担体の表面に細胞を付着させ、これを
攪拌しながら培養を行う、いわゆるマイクロキャリアー
培養が有効であることが知られている。
Jubei Saban: Conventionally, in order to mass culture cultured cells that grow in an adherent manner, that is, adhesion-dependent cells, cells are attached to the surface of a cylindrical bottle with a large surface area, and the bottle is rotated for cultivation. It is known that so-called microcarrier culture, in which cells are attached to the surface of a dish culture or a particulate carrier and cultured while stirring, is effective.

しかし、動物正常細胞、例えばt−ブラスミノ−ゲンア
クチベーター産生細胞であるヒトiin織由来の正常2
倍体線維芽細胞では上記マイクロキャリアー培養を行う
場合、細胞の増殖を伴なって起るブリッジング現象並び
に攪拌による剪断作用のために細胞がマイクロキャリア
ーがら剥離し易くなる。また、有用物質生産のための無
血清培地では特に攪拌による剪断力により細胞が担体か
ら剥離し昌<、細胞は死滅して安定した物質生産ができ
なくなるという問題がある。
However, animal normal cells, such as normal 2 derived from human IIN tissue, which is a t-blasminogen activator producing cell.
When culturing the above-mentioned microcarriers in the case of diploid fibroblasts, the cells tend to peel off from the microcarriers due to the bridging phenomenon that occurs with cell proliferation and the shearing action caused by stirring. In addition, serum-free media for the production of useful substances have the problem that the shearing force caused by agitation causes the cells to detach from the carrier and die, making stable substance production impossible.

また、遊離性或は付着性のガン細胞や形質転換細胞をア
ルギン酸カルシウム等のゲル体内に包埋して培養するこ
とにより、大量培養を行う方法も知られているが、この
包埋培養法を付着性の動物正常細胞に通用して培養を行
っても細胞の増殖はみられない。
There is also a known method for mass culturing free or adherent cancer cells or transformed cells by embedding them in a gel body such as calcium alginate. No cell proliferation is observed even when cultured in a manner similar to normal adherent animal cells.

しかして、近年、t−プラスミノーゲンアクチベーター
の生産にみられるごとく、動物正常細胞の培養を利用し
て有用な生理活性物質を生産する技術の開発に伴ない、
動物正常細胞大量培養の技術の確立が要望されている。
However, in recent years, as seen in the production of t-plasminogen activator, with the development of technology to produce useful physiologically active substances using the culture of normal animal cells,
There is a need to establish a technology for mass culture of normal animal cells.

明が7ンしようとするW題 本発明は、叙上の状況に鑑みなされたものであって、付
着性動物正常細胞を高密度で大量培養するための包埋培
養法を提供することを課題とする。
The present invention was made in view of the above-mentioned circumstances, and an object thereof is to provide an embedding culture method for culturing adherent animal normal cells in large quantities at high density. shall be.

本発明者は、付着性動物正常細胞を、微粒子状の生体高
分子担体に付着させたものを、アルギン酸カルシウムの
ゲル体に包埋させることにより、上述したような細胞の
剥離現象を起すことなく高密度に大量培養し得ることに
成功し、本発明をなすに至った。
The present inventor has discovered that by embedding adherent normal animal cells attached to a microparticulate biopolymer carrier in a gel body of calcium alginate, the above-mentioned cell detachment phenomenon does not occur. We succeeded in culturing in large quantities at high density, leading to the present invention.

以下本発明の詳細な説明する。The present invention will be explained in detail below.

光凱(2)1底 本発明の特徴は、付着性動物正常細胞を微粒子状の生体
高分子担体に付着させたものを、生理的食塩水にアルギ
ン酸を溶解して除菌したアルギン酸溶液と混合してアル
ギン酸ゲルの最終?;度を0.3〜l、0%となし、次
いで該混合液を、非イオン性界面活性剤を含有させて滅
菌処理した塩化カルシウム溶液中に滴下して」記聞正常
細胞を包埋したアルギン酸カルシウムから成る微粒子担
体を作成し、該微粒子担体を血清添加培地等で培養する
ことにある。
Kokai (2) 1-bottom A feature of the present invention is that adherent normal animal cells adhered to a particulate biopolymer carrier are mixed with an alginic acid solution that has been sterilized by dissolving alginic acid in physiological saline. The final result of alginate gel? The concentration was adjusted to 0.3 to 0%, and then the mixture was dropped into a sterilized calcium chloride solution containing a nonionic surfactant to prepare alginic acid in which normal cells were embedded. The purpose is to prepare microparticle carriers made of calcium and to culture the microparticle carriers in a medium supplemented with serum or the like.

問を五太1Ak−杵q下段 本発明では、付着性動物正常細胞を、ゼラチン、コラー
ゲン等のような生体高分子を微粒子状に形成した担体、
すなわち、マイクロキャリアーに付着させたものを、ア
ルギン酸カルシウムのゲル体内に包埋させることが重要
である。
In the present invention, adherent animal normal cells are mixed with a carrier made of biopolymers such as gelatin, collagen, etc. in the form of fine particles.
That is, it is important to embed what is attached to the microcarrier in a gel body of calcium alginate.

上記生体高分子から成るマイクロキャリアーは、従来公
知の方法により形成することができる。このマイクロキ
ャリアーに上記正常細胞を付着さゼるには、マイクロキ
ャリアー1個当り5〜10個の細胞が付着するような細
胞密度で播種(、、炭酸ガスの5%濃度雰囲気のフラン
器内で1〜3時間前培養を行うとよい。
Microcarriers made of the above biopolymer can be formed by conventionally known methods. To attach the normal cells to the microcarriers, seed them at a cell density such that 5 to 10 cells adhere to each microcarrier (in a furan vessel with a 5% carbon dioxide atmosphere). Pre-cultivation is preferably performed for 1 to 3 hours.

上述のようにしてマイクロキャリアーに付着させた細胞
は、下記のようにして調製したアルギン酸溶液と混合す
る。
The cells attached to the microcarriers as described above are mixed with an alginic acid solution prepared as described below.

アルギン酸溶液の調製二 〇、85%生理的食塩水にアルギン酸を1.6%濃度に
溶解し、この溶液をフィルター濾過により除菌する。こ
の除菌は当初0.8μ攬のフィルターを用い、次に0.
45μmのフィルターを用い、R1&に0.22μlの
フィルターを用いて行うとよい。
Preparation of alginic acid solution 20. Dissolve alginic acid to a concentration of 1.6% in 85% physiological saline, and sterilize this solution by filtering. This sterilization was initially carried out using a 0.8 μm filter, then a 0.8 μm filter.
It is recommended to use a 45 μm filter and a 0.22 μl filter for R1&.

このようにして1周製したアルギン酸溶液を、−上記細
胞を付着させたマイクロキャリアーと混合し、その際、
アルギン酸ゲルの最終濃度が()、3〜1.0%になる
ように混合を行う。この場合、混合後のアルギン酸ゲル
の最終4度が003%未満ではゲル強度が低くて攪拌に
耐えられず、一方、1.0%を超えると、ゲル内のマイ
クロキャリアー上での細胞の生育が抑制される。
The alginate solution prepared once in this way is mixed with the microcarriers to which the above-mentioned cells have been attached, and at this time,
Mixing is performed so that the final concentration of alginate gel is (), 3-1.0%. In this case, if the final 4 degree of the alginate gel after mixing is less than 0.03%, the gel strength will be low and will not be able to withstand stirring, while if it exceeds 1.0%, the growth of cells on the microcarriers in the gel will be inhibited. suppressed.

次いで、上記混合液を、下記のようにして調製した塩化
カルシウム溶液中に滴下してアルギン酸カルシウムから
成る微粒子包埋体担体(マクロキャリアー)を作成する
Next, the above liquid mixture is dropped into a calcium chloride solution prepared as described below to prepare a microparticle embedding carrier (macrocarrier) made of calcium alginate.

塩化カルシウム溶液の調製: 非イオン性界面活性剤、好ましくはソルビタンモノオレ
アートのエチレンオキシド縮合物(Tween80:の
o、 ooi%〜0.01%添加した50〜100+1
M ?m度の塩化カルシウム水溶液をオートクレーブで
滅菌した後、室温下に放冷する。ここで用いる塩化カル
シウム水溶液に添加した非イオン性界面活性剤は、アル
ギン酸ナトリウム溶液の滴下時の包埋ゲルの形成を容易
にするために、塩化カルシウム溶液の表面張力を下げる
のに役立つ。
Preparation of calcium chloride solution: 50-100+1 with the addition of a non-ionic surfactant, preferably an ethylene oxide condensate of sorbitan monooleate (Tween 80: o, ooi% to 0.01%)
M? After sterilizing the calcium chloride aqueous solution in an autoclave, it is allowed to cool to room temperature. The nonionic surfactant added to the calcium chloride aqueous solution used here serves to lower the surface tension of the calcium chloride solution to facilitate the formation of an embedding gel upon dropping the sodium alginate solution.

−1−記塩化カルシウム溶液へのE述した混合液の滴下
は、従来、ガン細胞等の包埋培養に用いるマクロキャリ
アーの作成方法に従って行うとよい。
-1- The above-mentioned mixed solution may be added dropwise to the calcium chloride solution in accordance with conventional methods for preparing macrocarriers used for embedding culture of cancer cells and the like.

すなわち、マクロキャリア〜の作成は、アルギン酸ナト
リウムと細胞付着マイクロキャリアーとの上述の混合液
を、ノズル(又は滅菌ピペット)から滅菌塩化カルシウ
ムに0.001〜0.01%のTween80を添加し
た溶液に滴下することによって作成される。マクロピー
スの大きさは、ノズルの径を自由に変えることによって
コントロールすることができる。生成したマクロキャリ
アー中に細胞の付着したマイクロキャリアーが包埋され
る。 上記マイクロキャリアーにおける細胞濃度は、マ
イクロキャリアー1個当り細胞が5〜10ケ包埋された
程度となるや 上述のようにして作成された細胞包埋のマクロキャリア
ーは、細胞及びマイクロキャリアーが、アルギン酸ゲル
に固定された状態にあるため、培養に際して、前述した
ようなマイクロキャリアーに付着させた細胞のようにブ
リッジング現象や撹拌作用により剥離することがなく、
また、外的環境因子の影響を受けることも少ないので、
細胞自体のロンジビテイ(longev i ty) 
も長くなる。
That is, to create the macrocarrier, the above-mentioned mixture of sodium alginate and cell-attached microcarriers is added to a solution of sterile calcium chloride with 0.001 to 0.01% Tween 80 added through a nozzle (or sterile pipette). Created by dripping. The size of the macro piece can be controlled by freely changing the diameter of the nozzle. Microcarriers with attached cells are embedded in the generated macrocarriers. The cell concentration in the above microcarrier is such that 5 to 10 cells are embedded in each microcarrier. Because they are fixed in the gel, they do not come off during culture due to bridging or agitation, unlike cells attached to microcarriers as described above.
In addition, it is less affected by external environmental factors, so
longevity of the cell itself
is also longer.

したがって、このマクロキャリアーを例えば血清添加培
地で培養すると付着依存性の動物正常細胞を高密度に大
量培養することが可能となる。
Therefore, by culturing this macrocarrier in, for example, a serum-supplemented medium, it becomes possible to culture adhesion-dependent normal animal cells in large quantities at high density.

なお、マイクロキャリアーへの細胞の付着は下記のよう
にして行い得る。
Note that cells can be attached to microcarriers in the following manner.

生体高分子(ゼラチン、コラーゲン等)から成るマイク
ロキャリアーをPBSで膨潤させ、次いで121 ’C
で10〜15分間オートクレーブで滅菌する。
Microcarriers made of biopolymers (gelatin, collagen, etc.) were swollen with PBS and then incubated at 121'C.
Sterilize in an autoclave for 10-15 minutes.

オートクレーブで滅菌したマイクロキャリアー懸濁液の
PBSを、10%FC3を加えた細胞培養用培地(DM
I?:M又はMEM)で置換後、マイクロキA・リアル
培養用スピナフラスコ中で付着性正常細胞をマイクロキ
ャリアー1個当り細胞が5〜lO個程度付着するように
接種し、5%COt雰囲気中に1〜4時聞かんけつ的に
攪拌する(30分間静置、1分間攪拌、これを1〜4時
間繰返す)。細胞が完全にマイクロキャリアーに付着後
、所定濃度のアルギン酸ナトリウムi8 ?flと混合
する(混合液中のアルギン酸ナトリウムの最終濃度0.
3〜1.0%にし、細胞付着マイクロキャリアーは所望
の濃度に自由に設定することができる)。
PBS of microcarrier suspension sterilized by autoclave was mixed with cell culture medium (DM) supplemented with 10% FC3.
I? :M or MEM), then inoculate adherent normal cells in a microcarrier spinner flask so that about 5 to 10 cells adhere to each microcarrier, and inoculate them in a 5% COt atmosphere. Stir vigorously at ~4 o'clock (leave for 30 minutes, stir for 1 minute, repeat for 1 to 4 hours). After the cells have completely attached to the microcarriers, a predetermined concentration of sodium alginate i8? fl (final concentration of sodium alginate in the mixture 0.
3-1.0%, and the cell-attached microcarriers can be freely set to the desired concentration).

以上述べたごとく、本発明に従って、付着依存性の動物
正常細胞を、生体高分子から成るマイクロキャリアーに
付着させたものをアルギン酸カルシウムのゲル体内に包
埋させて作成したマクロキャリアーとして培養すること
により、従来国運とされていた上記正常細胞の大量培養
が可能となるので、本発明は、正常細胞の培養により有
用な生理活性物質を生産する技術上非常に有益であると
いえる。
As described above, according to the present invention, by culturing adhesion-dependent animal normal cells as macrocarriers prepared by adhering them to microcarriers made of biopolymer and embedding them in a gel body of calcium alginate. The present invention can be said to be extremely useful in terms of technology for producing useful physiologically active substances by culturing normal cells, since it becomes possible to culture the above-mentioned normal cells in large quantities, which has conventionally been regarded as a national fortune.

以下に実施例を示して本発明を具体的に説明する。EXAMPLES The present invention will be specifically described below with reference to Examples.

実施例1 ヒト胎児肺由来正常2倍体線維芽細胞mMR−90(A
TCC,CCL−186)を、細胞培養フラスコ(T−
175enl)で80%集密状態まで培養を行った。得
られた倍長細胞を滅菌したPBSで洗浄し、培地成分を
除去した後、トリプシン処理を行って総細胞数5XlO
’個を得た。得られた細胞を10%FC3を添加したD
MEM (ダルベツコ変性イーグル培地、旧+1bec
eo’sModified Eagle Mediuw
l) 1.5m&に)懸濁した。
Example 1 Human fetal lung-derived normal diploid fibroblast mMR-90 (A
TCC, CCL-186) in a cell culture flask (T-
175 enl) until 80% confluence. The obtained double-length cells were washed with sterilized PBS to remove medium components, and then treated with trypsin to reduce the total number of cells to 5XlO.
'I got a piece. The obtained cells were added with 10% FC3.
MEM (Dulbetzko's modified Eagle's medium, old +1bec
eo'sModified Eagle Mediuw
l) Suspended at 1.5 m&).

一方、ゼラチンから形成されたマイクロキャリアー(ゼ
リービ=ス、KCバイオロジカル社製)をPBSで膨潤
させ、オートクレーブで滅菌後、1ン[3Sを10%F
C3を添加したI) M E Mで置換し、マイクロキ
ャリアー濃度を24μg/m lとなるよ・うに調製し
た。50++ 1容マ・fりロキャリアー11″rJ養
スピナボトルに上記の細胞懸濁液15m7!(細胞数5
X 1Oh)とマイクロキャリアー懸濁液5mJ(マイ
クロキャリアー量120mg)を入れ、ヘク1、スペー
スを5%CO□で置換後、30分間静置、1分間バ1件
の操作をかんけつ的に2〜3時間繰返し行って撹拌培養
した。細胞がマイクロキャリアーに完全に付着した後、
低速遠心(500〜600rpm、5分間)又は静直に
よりマイクロキャリアーを沈下させ、上清の培地を抜き
取ることにより、細胞付着マイクロギヤリアーを収集し
た。
On the other hand, microcarriers formed from gelatin (Jelibis, manufactured by KC Biological) were swollen with PBS, sterilized in an autoclave,
The microcarrier concentration was adjusted to 24 μg/ml by replacing it with I) MEM supplemented with C3. 50++ 15m7 of the above cell suspension in a 1 volume MA・FRIROCARRIER 11"rJ culture spinner bottle! (Number of cells: 5
Add 5 mJ of microcarrier suspension (120 mg of microcarriers), replace the space with 5% CO□, let it stand for 30 minutes, and repeat the operation for 1 minute twice. Stirring culture was carried out repeatedly for ~3 hours. After the cells have completely attached to the microcarriers,
Cell-adhered microcarriers were collected by sinking the microcarriers by low-speed centrifugation (500-600 rpm, 5 minutes) or by standing still, and removing the supernatant medium.

この細胞(1着マイクロキャリアーを30%FC3を含
L D M n M 15m l! L Q濁し、25
m 14の濾過滅菌を行った0、48%のアルギン酸す
トリウム溶液と混合した。
This cell (1 microcarrier containing 30% FC3 was suspended in 15 ml!
It was mixed with a 0.48% sodium alginate solution that had been sterilized by filtration.

得られた混合液40m jl!を18ゲージの注射針の
ついた滅菌注射筒に入れ、圧力を加えながら、i/i!
菌した0、01%のTween80を含む50dの塩化
カルシウム溶液に滴下して細胞付着マイクロキャリアー
を包埋したアルギン酸ゲルマクロキャリアーを作成した
。最終アルギン酸ナトリウムの濃度は0.3%であった
The resulting mixed liquid was 40mjl! into a sterile syringe fitted with an 18-gauge needle, and while applying pressure, inject i/i!
Alginate gel macrocarriers were prepared by embedding cell-attached microcarriers by dropping them into a 50 d calcium chloride solution containing 0.01% Tween 80. The final sodium alginate concentration was 0.3%.

次に、上記細胞付着マイクロキャリアーの懸濁液とアル
ギン酸ナトリウム溶液との混合液40m Qを、各群5
alづつに等分しながら、計8群のマクロキャリアーを
形成した。各マクロキャリアーを作成後、30〜60分
以内に塩化カルシウム溶液を生理的食塩水で置換洗浄し
、次いで10%FC3を添加し、DMEMで胃洗浄した
Next, 40 m Q of a mixture of the cell-attached microcarrier suspension and sodium alginate solution was added to each group, 5
A total of 8 groups of macrocarriers were formed by equally dividing each macrocarrier into al. After each macrocarrier was prepared, the calcium chloride solution was replaced with physiological saline for washing within 30 to 60 minutes, then 10% FC3 was added, and the stomach was washed with DMEM.

上述のようにして培地で洗浄したマクロキャリアーを、
T線で滅菌した250s I!容ポリスチレンボトル(
コーニング社製)に移し、10%FC3添加I) M 
rE Mを各群に50ta eそれぞれ添加し、ヘッド
スペースに5%COzを吹き込み、細菌培養用振とう培
養機にセットし、40rp鋼で振とうしながら、37℃
で10日間培養を行った。
The macrocarriers washed with the medium as described above are
250s I sterilized with T-ray! polystyrene bottle (
Corning) and added 10% FC3 I) M
50 tae of rEM was added to each group, 5% COz was blown into the headspace, and the mixture was placed in a shaking incubator for bacterial culture and incubated at 37°C while shaking with a 40RP steel.
Culture was performed for 10 days.

培養後、上記8群のうち4群は細胞数の測定に、他の4
群はL−ブラスミノーゲンアクチベーターの生産に用い
た。t−ブラスミノーゲンアクヂベーターの生産は、マ
クロキャリアー培養液(37℃で、10日間培養したも
の)からビベツ(・で培地だけ抜き取り、生理的食塩水
又はPΔSでマクロキャリアーを洗浄して培地成分を除
去した後、1%プロテオースベブトン及び0,01%T
ween80を添加したi)MEM10抛Pを加え、3
7℃で7日間40rpmで同様に振とうしながら培養し
て行った。ここで0、O1%Tween80を培地に添
加するのは、t−プラスミノーゲンアクチベーターをマ
クロキャリアー中で吸着させずに、マクロキャリアーか
ら培地に円滑に放出させるためである。
After culturing, 4 of the above 8 groups were used to measure the number of cells, and the other 4 groups were
The group was used for the production of L-blasminogen activator. To produce t-blasminogen activator, only the medium is removed from the macrocarrier culture solution (cultivated at 37°C for 10 days) using a bibet, and the macrocarrier is washed with physiological saline or PΔS to remove the medium components. After removing 1% proteose bebutone and 0.01% T
i) Add MEM10P to which ween80 was added, 3
The cells were cultured at 7° C. for 7 days with shaking at 40 rpm. The reason why 0.01% Tween 80 is added to the medium is to prevent the t-plasminogen activator from being adsorbed in the macrocarrier and to smoothly release it from the macrocarrier into the medium.

また、上記培養後の細胞数の測定は、アルギン酸ゲルか
らなるマクロキャリアーを100mMをEDTA (エ
チレンジアミンテトラ酢酸)で溶解した後、細胞付着マ
イクロキャリアーを遠心分離(600〜QOOrp曙、
10分間)により収集してトリプシン処理を行って、マ
イクロキャリアーから細胞を剥乱して計測した。
In addition, to measure the number of cells after the above culture, after dissolving 100mM of macrocarriers made of alginate gel with EDTA (ethylenediaminetetraacetic acid), centrifuging the cell-attached microcarriers (600~QOOrp Akebono,
The microcarriers were harvested for 10 minutes, treated with trypsin, and the cells were detached from the microcarriers and counted.

上記計測した結果、各ボトルの平均細胞数は、培養開始
時で5X10’/ボトル(マイクロキャリアー1個当り
細胞平均8個)のものが、37℃で10日間培養後、3
.5 X 10”/ボトルであった。
As a result of the above measurement, the average number of cells in each bottle was 5 x 10'/bottle (average 8 cells per microcarrier) at the start of culture, and 3 cells after 10 days of culture at 37°C.
.. It was 5 x 10"/bottle.

また、一方、(−ブラスミノーゲンアクチベーターの培
養日数による生産状況は表1のとおりであった。
On the other hand, the production status of (-blasminogen activator) according to the number of culture days is as shown in Table 1.

表1 実施例2 ヒト胎児肺由来正常2(i’W体線維芽細胞mMR−9
0(ATCC、CCL−186)を実施例1と同様にT
−フラスコで培養して種細胞4.5 X 10’を得、
マイクロキャリアー (ゼリービーズ、KCバイオロジ
カル社製)120mgに付着させた。この細胞付着マイ
クロキャリアー (マイクロキャリアー量120mg)
の懸濁液15mj!を、濾過滅菌した0、8/のアルギ
ン酸ナトリウム溶液25m j!と混合し、混合液40
m iを得た。
Table 1 Example 2 Human fetal lung-derived normal 2 (i'W body fibroblast mMR-9
0 (ATCC, CCL-186) as in Example 1.
- culture in flasks to obtain 4.5 x 10' seed cells;
It was attached to 120 mg of microcarriers (jelly beads, manufactured by KC Biological). This cell-attached microcarrier (microcarrier amount 120mg)
suspension of 15mj! , 25mj of filter sterilized 0.8% sodium alginate solution! Mix with 40% of the mixed liquid
I got m i.

この混合’111 (40m l )を各5mnづつ8
等分しながら、5鵬l用ピペツトの尖端から0.01%
Tween80を含む50+++M CaC1,溶液に
それぞれ滴下し、アルギン酸ビーズマクロキャリアーを
作成した。このマクし】キャリアーのアルギン酸すトリ
ウムの最終濃度は0.5%となり、細胞((j着マイク
ロキャリア〜はマクロキャリアー内に包埋固定された。
This mixture '111 (40 ml) was added to 8
While dividing into equal parts, add 0.01% from the tip of a 5-liter pipette.
They were each added dropwise to a 50++M CaCl solution containing Tween 80 to prepare alginate bead macrocarriers. The final concentration of sodium alginate in the carrier was 0.5%, and the microcarriers attached to the cells were embedded and fixed in the macrocarriers.

なお、」、記のように5m!!用ビペッ1−の尖端を滴
下のためノズルに用いた時には、形成したマクロキャリ
アーの径は約4〜5mtaであった。
In addition, 5m as stated! ! When the tip of the pipette 1- was used as a nozzle for dropping, the diameter of the macrocarriers formed was about 4 to 5 mta.

次に、このようにして得られた各群(上記8等分した群
)のマクロキャリアーを、実施例1と同様にして洗浄後
、10%FC3添加DMEM50mItに懸濁後、25
0m l容ポリスチレンボトル(コーニング社製)に移
し、細菌培養用振とう培養器で回転数100「東で振と
うしながら、37℃で10日間培養した。
Next, the macrocarriers of each group thus obtained (groups divided into 8 equal parts) were washed in the same manner as in Example 1, suspended in 50 mIt of DMEM supplemented with 10% FC3, and then
The mixture was transferred to a 0 ml polystyrene bottle (manufactured by Corning) and cultured at 37°C for 10 days while shaking at 100 rpm in a shaking incubator for bacterial culture.

培養後、8群のうちの4群は細胞数測定に用い、たの4
群はt−プラスミノーゲンアクチベーターの生産に用い
た。
After culturing, 4 of the 8 groups were used for cell count measurement;
The group was used for the production of t-plasminogen activator.

トブラスミノーゲンアクチベーターの生産は、回転数を
1100rpとした以外は、実施例1に記載したと同様
の手順で行った。
Toblasminogen activator was produced in the same manner as described in Example 1, except that the rotational speed was 1100 rpm.

細胞数の測定並びにt−プラスミノーゲンアクチベータ
ーの生産の結果は表2並びに表3に示すとおりである。
The results of cell number measurement and t-plasminogen activator production are shown in Tables 2 and 3.

実施例3 ヒト胎児腎由来正常2倍体線維芽細胞Flow 400
0を、実施例1と同様にしてT−フラスコで培養して種
細胞?、I X 10′′を得、マイクロキャリアー(
コラーゲンビーズ、フナイ薬品社製) 168mgに付
着させた。
Example 3 Human fetal kidney-derived normal diploid fibroblast cell Flow 400
0 was cultured in a T-flask in the same manner as in Example 1 to obtain seed cells. , I X 10'' and microcarrier (
Collagen beads (manufactured by Funai Yakuhin Co., Ltd.) (168 mg) were attached.

この細胞付着マイクロキャリアー(マイク[J−トヤリ
アー量168mg)の懸濁液18.5m/と、濾過滅菌
した1、6%のアルギン酸ナトリウム溶液31.5mf
fを混合し、計50117!の混合液とした。
18.5 m/ml of a suspension of this cell-attached microcarrier (Mike [J-Toyaria amount: 168 mg) and 31.5 mf/filter-sterilized 1.6% sodium alginate solution.
Mix f, total 50117! A mixed solution of

この混合液(5(bw iりを各5mfづつ10等分し
ながら、5II!!用ピペツトの尖端から、0.O1%
Tween80を含む50mM CaCIz溶液にそれ
ぞれ滴下してアルギン酸ビーズマクロキャリアーを作成
した。このマクロキャリアーのアルギン酸ナトリウムの
最終濃度は1.0%となり、細胞付着マイクロギヤリア
〜 (コラーゲンビーズ)は、上記マクロキャリアー内
に包埋固定顎された。なお、マクロビーズの径は約4m
111であった。
Divide this mixed solution (5 (bwi) into 10 equal parts of 5 mf each and pipette with 0.01%
Alginate bead macrocarriers were prepared by dropping each into a 50mM CaCIz solution containing Tween 80. The final concentration of sodium alginate in this macrocarrier was 1.0%, and the cell-attached microgearia (collagen beads) were embedded and fixed in the macrocarrier. The diameter of macro beads is approximately 4 m.
It was 111.

上述のようにして得られた各群(10群)のマクロキャ
リアーを洗浄した後、10%FC3添加DMEM50s
I!に懸濁させた後、250a+ 1容ポリスチレンボ
トル(コーニング社製)に移し、細菌培養用振とう培養
機で回転数100rp−で振とうしながら、37℃で1
0日間培養した。
After washing the macrocarriers of each group (10 groups) obtained as described above, DMEM50s containing 10% FC3 was added.
I! After suspending the suspension in 250a+ 1 volume polystyrene bottle (manufactured by Corning), it was incubated at 37°C for 1 hour while shaking at 100 rpm in a shaking incubator for bacterial culture.
Cultured for 0 days.

培養後、10群のうちの5群は細胞数の測定に用い、他
の5群はL−プラスミノーゲンアクチベーターの生産に
用いた。
After culturing, 5 of the 10 groups were used to measure the number of cells, and the other 5 groups were used to produce L-plasminogen activator.

トブラスミノーゲンアクチベーターの生産は、回転数1
00rps+とじた以外は、実施例1に記載したと同様
の手順で行った。
Toblasminogen activator production is performed at a rotational speed of 1
The same procedure as described in Example 1 was followed except that 00rps+ binding was performed.

細胞数測定並びにt−ブラスミノーゲンアクチベーター
生産の結果は表4並びに表5に示すとおりである。
The results of cell number measurement and t-blasminogen activator production are shown in Tables 4 and 5.

Claims (4)

【特許請求の範囲】[Claims] (1)付着性動物正常細胞を微粒子状の生体高分子担体
に付着させたものを、生理的食塩水にアルギン酸を溶解
して除菌したアルギン酸溶液と混合してアルギン酸ゲル
の最終濃度を0.3〜1.0%となし、次いで該混合液
を、非イオン性界面活性剤を添加して含有させた滅菌処
理した塩化カルシウム溶液中に滴下して上記担体に付着
の正常細胞を包埋したアルギン酸カルシウムから成る微
粒子担体(マクロキャリアー)を作成し、該微粒子担体
を培地で培養することを特徴とする付着性動物正常細胞
の包埋培養法。
(1) Adhesive normal animal cells adhered to a particulate biopolymer carrier are mixed with an alginic acid solution that has been sterilized by dissolving alginic acid in physiological saline, and the final concentration of the alginate gel is adjusted to 0. 3 to 1.0%, and then the mixture was dropped into a sterilized calcium chloride solution containing a nonionic surfactant to embed the normal cells attached to the carrier. 1. A method for embedding adherent animal normal cells, which comprises preparing microparticle carriers (macrocarriers) made of calcium alginate and culturing the microparticle carriers in a medium.
(2)上記動物正常細胞を、生体高分子担体に1×10
^5/mlキャリアー以上播種し、5%炭酸ガス雰囲気
中で1〜3時間前培養を行つて該担体に付着させる特許
請求の範囲第(1)項記載の包埋培養法。
(2) 1 x 10 of the above animal normal cells on a biopolymer carrier
The embedding culture method according to claim (1), wherein the seeds are seeded in 5%/ml carrier or more, precultured for 1 to 3 hours in a 5% carbon dioxide atmosphere, and then attached to the carrier.
(3)アルギン酸溶液は、0.85%生理的食塩水にア
ルギン酸を1.6%の濃度に溶解し、フィルター濾過に
より除菌したものである特許請求の範囲第(1)項記載
の包埋培養法。
(3) The embedding according to claim (1), wherein the alginic acid solution is obtained by dissolving alginic acid at a concentration of 1.6% in 0.85% physiological saline and sterilizing it by filter filtration. Culture method.
(4)塩化カルシウム溶液は、非イオン性界面活性剤と
してソルビタンモノオレアートのエチレンオキシド縮合
物を0.001〜0.01%を含有させた塩化カルシウ
ム濃度が50mMの溶液である特許請求の範囲第(1)
項記載の包埋培養法。
(4) The calcium chloride solution is a solution containing 0.001 to 0.01% of an ethylene oxide condensate of sorbitan monooleate as a nonionic surfactant and having a calcium chloride concentration of 50 mM. (1)
Embedded culture method described in section.
JP62041442A 1987-02-26 1987-02-26 Embedding culture method of adhesion-dependent animal normal cells Expired - Lifetime JPH07100029B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62041442A JPH07100029B2 (en) 1987-02-26 1987-02-26 Embedding culture method of adhesion-dependent animal normal cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62041442A JPH07100029B2 (en) 1987-02-26 1987-02-26 Embedding culture method of adhesion-dependent animal normal cells

Publications (2)

Publication Number Publication Date
JPS63209581A true JPS63209581A (en) 1988-08-31
JPH07100029B2 JPH07100029B2 (en) 1995-11-01

Family

ID=12608483

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62041442A Expired - Lifetime JPH07100029B2 (en) 1987-02-26 1987-02-26 Embedding culture method of adhesion-dependent animal normal cells

Country Status (1)

Country Link
JP (1) JPH07100029B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264359A (en) * 1988-04-18 1993-11-23 Nitta Gelatin Inc. Methods for large-scale cultivation of animal cells and for making supporting substrata for the cultivation
WO2014017513A1 (en) 2012-07-24 2014-01-30 日産化学工業株式会社 Culture medium composition, and method for culturing cell or tissue using said composition
WO2015111686A1 (en) 2014-01-23 2015-07-30 日産化学工業株式会社 Culture medium composition
WO2015111685A1 (en) 2014-01-23 2015-07-30 日産化学工業株式会社 Method for producing culture medium composition
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
JP2019075993A (en) * 2017-10-20 2019-05-23 国立大学法人 東京大学 Method for three-dimensional culture of cells, cell structure, method for producing cell structure and method for carrying cells

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264359A (en) * 1988-04-18 1993-11-23 Nitta Gelatin Inc. Methods for large-scale cultivation of animal cells and for making supporting substrata for the cultivation
KR20210022778A (en) 2012-07-24 2021-03-03 닛산 가가쿠 가부시키가이샤 Culture medium composition, and method for culturing cell or tissue using said composition
KR20210118251A (en) 2012-07-24 2021-09-29 닛산 가가쿠 가부시키가이샤 Culture medium composition, and method for culturing cell or tissue using said composition
KR20190133287A (en) 2012-07-24 2019-12-02 닛산 가가쿠 가부시키가이샤 Culture medium composition, and method for culturing cell or tissue using said composition
US10590380B2 (en) 2012-07-24 2020-03-17 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US11371013B2 (en) 2012-07-24 2022-06-28 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
KR20150038190A (en) 2012-07-24 2015-04-08 닛산 가가쿠 고교 가부시키 가이샤 Culture medium composition, and method for culturing cell or tissue using said composition
EP3409761A1 (en) 2012-07-24 2018-12-05 Nissan Chemical Corporation Culture medium composition, and method for culturing cell or tissue using said composition
KR20220147706A (en) 2012-07-24 2022-11-03 닛산 가가쿠 가부시키가이샤 Culture medium composition, and method for culturing cell or tissue using said composition
WO2014017513A1 (en) 2012-07-24 2014-01-30 日産化学工業株式会社 Culture medium composition, and method for culturing cell or tissue using said composition
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
WO2015111685A1 (en) 2014-01-23 2015-07-30 日産化学工業株式会社 Method for producing culture medium composition
WO2015111686A1 (en) 2014-01-23 2015-07-30 日産化学工業株式会社 Culture medium composition
KR20210034121A (en) 2014-01-23 2021-03-29 닛산 가가쿠 가부시키가이샤 Culture medium composition
KR20220020418A (en) 2014-01-23 2022-02-18 닛산 가가쿠 가부시키가이샤 Culture medium composition
KR20220088523A (en) 2014-01-23 2022-06-27 닛산 가가쿠 가부시키가이샤 Culture medium composition
KR20160117496A (en) 2014-01-23 2016-10-10 닛산 가가쿠 고교 가부시키 가이샤 Culture medium composition
JP2019075993A (en) * 2017-10-20 2019-05-23 国立大学法人 東京大学 Method for three-dimensional culture of cells, cell structure, method for producing cell structure and method for carrying cells

Also Published As

Publication number Publication date
JPH07100029B2 (en) 1995-11-01

Similar Documents

Publication Publication Date Title
Bodiou et al. Microcarriers for upscaling cultured meat production
JP7036165B2 (en) Medium composition
US20160206780A1 (en) Matrix Scaffold for Three-Dimensional Cell Cultivation, Methods of Construction Thereof and Uses Thereof
CN105288737B (en) A kind of tissue engineering bone/cartilage compound rest and preparation method thereof
EP3713999A1 (en) Dissolvable foam scaffolds for cell culture and methods of making the same
Chui et al. Electrosprayed genipin cross‐linked alginate–chitosan microcarriers for ex vivo expansion of mesenchymal stem cells
RO115176B1 (en) Process for producing a virus in an aggregate microcarrier-cell culture
CN111334466B (en) Mesenchymal stem cell ball, preparation method and application thereof, and application of balling culture medium in preparation of mesenchymal stem cell ball
Overstreet et al. Collagen microcarrier spinner culture promotes osteoblast proliferation and synthesis of matrix proteins
CN111676191A (en) Method for three-dimensionally culturing mesenchymal stem cells based on Collagel gel scaffold method
JPS63209581A (en) Embedding culture of attachment-dependent animal normal cell
CN103881908A (en) Bioreactor system for cell co-cultivation
WO2016039391A1 (en) Method for cell recovery
CN110951686A (en) Hematopoietic stem cell in-vitro amplification culture system and method
Spahr et al. Microcarrier cultures of endothelial cells
JPH02234670A (en) Base material for cell culture
KR101639454B1 (en) Scalable process for culturing per.c6 cells and producing products therefrom
CN114410574B (en) Preparation method of chondrocyte in-vitro three-dimensional culture system
JP7526384B2 (en) Cell Culture Substrate
Shahar et al. Cerebral neurons, skeletal myoblasts, and cardiac muscle cells cultured on macroporous beads
CN116083363A (en) Application of composite hydrogel in promotion of cell balling culture
US20210371824A1 (en) Production of megakaryocytes in bioreactors
Brose et al. Co-culture of Human Articular Chondrocytes Seeded in Polyurethane Scaffolds and Human Mesenchymal Stromal Cells Encapsulated in Alginate Beads
JP2987441B1 (en) Animal cell immobilization method
WO2024134178A1 (en) Cell culturing of adherent cells